Academic Footprint CCG’s MOE and PSILO are widely adopted in teaching and research across more than 600 universities worldwide, indicating strong familiarity and potential for upsell or cross-sell of licensing, training, and specialized modules to academic institutions and consortia.

Life Sciences Focus Operating in software for life sciences with products spanning molecular modeling, CAMD, bioinformatics, and macromolecular databases, there are opportunities to expand into drug discovery workflows, SAR analysis, and comprehensive data management solutions for pharma, biotech, and academic collaborations.

Recent Growth CCG’s acquisition of Discngine and ongoing participation in industry events signals expansion and integration potential; this presents a path to offer integration services, data migration, and unified platform experiences for customers adopting Discngine’s capabilities alongside MOE and PSILO.

Global Reach With headquarters in Montreal and support offices across North America, Europe, and Asia, there is potential to tailor regional licensing models, localized training, and support bundles to accelerate adoption in target markets and optimize channel partnerships.

Financial Opportunity Estimated revenue in the $10M–$25M range suggests mid-market focus with room for expansion through enterprise-grade subscriptions, annual maintenance, and premium support, plus targeted upsell to larger pharma and biotech clients seeking integrated computational life science platforms.